Breaking News
February 23, 2019 - Study gives a snapshot of crocodile evolution
February 23, 2019 - Research finds steep rise in self-poisonings among young people
February 23, 2019 - American Gastroenterological Association announces “AGA Future Leaders Program”
February 23, 2019 - Scientists uncover new mechanisms regulating neural stem cells
February 23, 2019 - Combinations of certain insecticides turn out to be lethal for honeybees
February 23, 2019 - AHA News: Why Are Black Women at Higher Risk of Dying From Pregnancy Complications?
February 23, 2019 - NIMH » Anxiety Disorders
February 23, 2019 - Autistic people urgently need access to tailored mental health support
February 23, 2019 - Newly designed molecule could benefit people with Friedrich’s Ataxia
February 23, 2019 - Chinese CRISPR twins may have better cognition and memory
February 23, 2019 - Study finds new genetic clues associated with asthma in African ancestry populations
February 23, 2019 - Fetal signaling pathways may offer future opportunities to treat lung damage
February 23, 2019 - Early-stage osteoarthritis drug wins prestigious innovation award
February 23, 2019 - Researchers report positive findings with dasotraline for ADHD in children ages 6-12
February 23, 2019 - News study reanalyzes the effects of noncaloric sweeteners on gut microbiota
February 23, 2019 - New device allows scientists to reproduce blow effects on the heart in lab
February 23, 2019 - Holy herb identified as a potential treatment for Alzheimer’s disease
February 23, 2019 - New technology platform digitally counts growth factors in single cells
February 23, 2019 - Surgery and other treatments offer viable options for adult scoliosis
February 23, 2019 - Reduced antibody adaptability may make the elderly more vulnerable to influenza
February 23, 2019 - Neighborhood income, education associated with risk of disability progression in MS patients
February 23, 2019 - 2019 guidelines for management of patients with atrial fibrillation
February 23, 2019 - Surprise rheumatoid arthritis discovery points to new treatment for joint inflammation
February 23, 2019 - A just-right fix for a tiny heart
February 23, 2019 - UMass Amherst scientist explores role of citrus peel in decreasing gut inflammation
February 23, 2019 - Owlstone Medical and Shanghai Renji Hospital collaborate to initiate breath biopsy lung cancer trial
February 23, 2019 - AMSBIO’s comprehensive portfolio of knock-out cell lines and lysates
February 23, 2019 - New app reliably determines physicians’ skills in forming accurate, efficient diagnoses
February 23, 2019 - Peripheral nerve injury can trigger the onset and spread of ALS, shows study
February 23, 2019 - Researchers uncover mechanisms that prevent tooth replacement in mice
February 23, 2019 - Once-a-day capsule offers new way to reduce symptoms of chronic breathlessness
February 23, 2019 - FDA Adds Boxed Warning for Increased Risk of Death with Gout Medicine Uloric (febuxostat)
February 23, 2019 - Phone-based intervention aids rheumatoid arthritis care
February 23, 2019 - Opioid epidemic makes eastern inroads and targets African-Americans
February 23, 2019 - New identified biomarker predicts patients who might benefit from HER2-targeted agents
February 23, 2019 - Study offers new insights into mechanisms of changes in erythrocytes under stress
February 23, 2019 - Antipsychotic polypharmacy may be beneficial for schizophrenia patients
February 23, 2019 - Researchers investigate how marijuana and tobacco co-use affects quit attempts by smokers
February 23, 2019 - Patients with diabetes mellitus have high risk of stable ischemic heart disease
February 23, 2019 - Transparency on healthcare prices played key role in Arizona health system’s turnaround
February 23, 2019 - A comprehensive, multinational review of peppers around the world
February 23, 2019 - Study finds modest decrease in burnout among physicians
February 23, 2019 - A simple change can drastically reduce unnecessary tests for urinary tract infections
February 23, 2019 - Deep Learning-Enhanced Device Detects Diabetic Retinopathy
February 23, 2019 - Researchers discover new binding partner for amyloid precursor protein
February 23, 2019 - Modest decrease seen in burnout among physicians, researchers say | News Center
February 23, 2019 - Transplanting bone marrow of young mice into old mice prevents cognitive decline
February 23, 2019 - Mogrify to accelerate novel IP and cell therapies using $3.7m USD funding
February 23, 2019 - Johns Hopkins study describes cells that may help speed bone repair
February 23, 2019 - Scientists demonstrate influence of food odors on proteostasis
February 23, 2019 - Researchers unlock the secret behind reproduction of fish called ‘Mary’
February 23, 2019 - Acupuncture Could Help Ease Menopausal Symptoms
February 23, 2019 - Researchers use AI to detect early signs of Alzheimer’s
February 23, 2019 - On recovery, vulnerability and ritual: An exhibit in white | News Center
February 23, 2019 - Memory Stored in Unexpected Region of the Brain
February 23, 2019 - Several health experts worldwide gather at EUDONORGAN event
February 23, 2019 - Discovery of potent compound in native California shrub may lead to treatment for Alzheimer’s
February 22, 2019 - Researchers create new map of the brain’s own immune system
February 22, 2019 - ICHE’s reviews on surgical infections, unnecessary urine tests, and nurses’ role in antibiotic stewardship
February 22, 2019 - UK Research and Innovation invests £200 million to create new generation of AI leaders
February 22, 2019 - Takeda collaboration to boost fight against Alzheimer’s and other neurodegenerative diseases
February 22, 2019 - Heavy drinking may change DNA, leading to increased craving for alcohol
February 22, 2019 - U.S. opioid deaths jump fourfold in 20 years; epidemic shifts to Eastern states | News Center
February 22, 2019 - 5 Questions with William Turner on Diversity in Medicine
February 22, 2019 - HHS Finalizes Rule Seeking To Expel Planned Parenthood From Family Planning Program
February 22, 2019 - Researchers uncover biochemical pathway that may help identify drugs to treat Alzheimer’s
February 22, 2019 - Biologist uses new grant to find ways to eliminate schistosomiasis
February 22, 2019 - Bag-mask ventilation to help patients breathe during intubation prevents complications
February 22, 2019 - AbbVie Announces New Drug Application Accepted for Priority Review by FDA for Upadacitinib for Treatment of Moderate to Severe Rheumatoid Arthritis
February 22, 2019 - Nature versus nurture and addiction
February 22, 2019 - New website connects researchers with data experts, resources | News Center
February 22, 2019 - Today’s Concerns About Drug Prices Echo The Past
February 22, 2019 - CT and Doppler equipment have low accuracy in detecting cerebral vasospasm and ischemia
February 22, 2019 - Study finds out similarity in function between healthy retina cell and tumor cell
February 22, 2019 - CWRU awarded NIH grant to identify effective treatments for intimate partner violence
February 22, 2019 - Oncotype DX Not Cost-Effective for Low-Risk Breast Cancer
February 22, 2019 - Scientists discover new type of immune cells that are essential for forming heart valves
February 22, 2019 - Talk About Déjà Vu: Senators Set To Re-Enact Drug Price Hearing Of 60 Years Ago
February 22, 2019 - Genetic defect linked to pediatric liver disease identified
February 22, 2019 - New cellular atlas could provide a deeper insight into blinding diseases
Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

Proton pump inhibitors in combination with oral anticoagulants reduce GI bleeding risk

image_pdfDownload PDFimage_print

A Vanderbilt University Medical Center (VUMC) study published today in JAMA shows that patients already at higher risk for gastrointestinal bleeding gain a marked protection from this risk when they take a proton pump inhibitor (PPI) in combination with an oral anticoagulant.

Oral anticoagulants, which prevent blood clot formation, are among the most widely prescribed medications in the United States. They are predominantly used for patients with an irregular heart rate called atrial fibrillation, prosthetic heart valves and those with or at risk for deep vein thrombosis and cardiovascular diseases. Unfortunately, a major side effect of oral anticoagulants is the risk of significant bleeding, particularly upper gastrointestinal bleeding.

“The data suggest that if you give a population oral anticoagulants, 1 to 1.5 percent will have major upper gastrointestinal bleeding every year; that’s a major side effect,” said lead author Wayne Ray, PhD, professor of Health Policy at VUMC. “We undertook this study to clarify what can be done to reduce upper gastrointestinal bleeding risk. We had three questions: what is the role of PPIs in reducing this risk, how do the newer oral anticoagulants differ in terms of the risk of this side effect and how do those factors change when you look at individuals already at higher risk for gastrointestinal bleeding? Those at higher risk would be those who have a history of ulcer disease, as well as individuals using other medications that increase bleeding risk.

“We actually found a marked protective effect for PPI use that reduced the risk of gastrointestinal bleeding by 34 percent. This risk reduction was most important among the highest risk patients where without a PPI the incidence of hospitalization for upper GI bleeding was 4 percent a year. Adding a PPI reduced that hospitalization rate to 2.8 percent per year.”

For more than six decades, warfarin was the most commonly prescribed oral anticoagulant, but its use has declined significantly as new oral anticoagulants have been approved by the Food and Drug Administration (FDA) that require less laboratory monitoring and have fewer drug and food interactions.

Ray and the same team of VUMC researchers published a 2016 study in the journal Gastroenterology that showed use of a PPI alongside warfarin reduced the risk of gastrointestinal bleeding. With many newer anticoagulants being prescribed and access to a large, national database of patient information, it made sense to undertake a large observational study including the newer drugs to measure and compare the co-therapy benefit, Ray said.

For the study, the research team pulled patient data from the Virtual Research Data Center, a database of the Centers for Medicare & Medicaid Services (CMS). The team identified 1.6 million patients who began oral anticoagulant therapy from 2011-2015. Patients were categorized based on those who also received PPIs and those who did not take PPIs. The incidence of hospitalizations for upper gastrointestinal bleeding was then compared. The team also compared the incidence of hospitalizations for this reason between four oral anticoagulant medications: apixaban, dabigatran and rivaroxaban and warfarin.

Among patients receiving oral anticoagulants, incidence of hospitalization for upper gastrointestinal bleeding was the highest for those taking rivaroxaban and lowest for apixaban. For each anticoagulant, the incidence was lower among patients who also received PPI co-therapy.

“Oral anticoagulants can be extremely valuable in preventing an ischemic stroke, which is one thing you really do not want to have happen, and we can’t lose sight of that,” Ray said. “On the other hand, they have potentially very dangerous side effects. What we’ve done with this study is show that clinicians can focus on a high-risk population and significantly improve care for those patients with the addition of a PPI. Basically, before anticoagulant therapy is started it would be beneficial to complete a gastrointestinal workup to measure patients’ existing risk factors and then tailor their therapy to take into account their risk status.”

Tagged with:

About author

Related Articles